These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6981429)

  • 1. Purification and characterization of human C1-esterase inhibitor.
    Nilsson T; Wiman B
    Biochim Biophys Acta; 1982 Jul; 705(2):271-6. PubMed ID: 6981429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and circular-dichroism studies on the interaction between human C1-esterase inhibitor and C1s.
    Nilsson T; Sjöholm I; Wiman B
    Biochem J; 1983 Sep; 213(3):617-24. PubMed ID: 6604523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new simple method for determination of C1-esterase inhibitor activity in plasma.
    Wiman B; Nilsson T
    Clin Chim Acta; 1983 Mar; 128(2-3):359-66. PubMed ID: 6602012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New preparation method of C1 esterase for the dosage of its plasma inhibitor].
    Gozin D; Ollier-Hartmann MP; Lerable J; Hartmann L; Soulier JP
    Biomed Pharmacother; 1983; 37(5):228-30. PubMed ID: 6607074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human complement component C1s. Partial sequence determination of the heavy chain and identification of the peptide bond cleaved during activation.
    Spycher SE; Nick H; Rickli EE
    Eur J Biochem; 1986 Apr; 156(1):49-57. PubMed ID: 3007145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthesis of complement C1 inhibitor by Hep G2 cells. Reactivity of different glycosylated forms of the inhibitor with C1s.
    Prandini MH; Reboul A; Colomb MG
    Biochem J; 1986 Jul; 237(1):93-8. PubMed ID: 3099750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of the reaction between human C1-esterase inhibitor and C1r or C1s.
    Nilsson T; Wiman B
    Eur J Biochem; 1983 Jan; 129(3):663-7. PubMed ID: 6297891
    [No Abstract]   [Full Text] [Related]  

  • 8. A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.
    de Agostini A; Patston PA; Marottoli V; Carrel S; Harpel PC; Schapira M
    J Clin Invest; 1988 Aug; 82(2):700-5. PubMed ID: 2457036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary structure of the reactive site of human C1-inhibitor.
    Salvesen GS; Catanese JJ; Kress LF; Travis J
    J Biol Chem; 1985 Feb; 260(4):2432-6. PubMed ID: 3919001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteolytic cleavage of an activated subcomponent of the first component of rabbit complement, C1s.
    Mori Y; Ueda E; Takeuchi T; Taniuchi S; Koyama J
    J Biochem; 1980 Jun; 87(6):1757-63. PubMed ID: 6447146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum activity of C1 inactivator in Duchenne-type progressive muscular dystrophy.
    Nagao N; Shomura I; Sawada Y
    Biochem Med Metab Biol; 1987 Jun; 37(3):385-8. PubMed ID: 3496913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in protein conformation and stability accompany complex formation between human C1 inhibitor and C1-s.
    Lennick M; Brew SA; Ingham KC
    Biochemistry; 1985 May; 24(10):2561-8. PubMed ID: 3874650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of C1s-C1 inhibitor complexes in plasma by means of an enzyme linked immunosorbent assay.
    Nilsson T; Bäck O
    Clin Exp Immunol; 1985 Apr; 60(1):178-82. PubMed ID: 3874014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of a proteinase inhibitor from bovine serum with C1-inhibitor activity.
    Van Nostrand WE; Cunningham DD
    Biochim Biophys Acta; 1987 Feb; 923(2):167-75. PubMed ID: 3814612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1.
    Chesne S; Villiers CL; Arlaud GJ; Lacroix MB; Colomb MG
    Biochem J; 1982 Jan; 201(1):61-70. PubMed ID: 6282262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of C1 inhibitor. A new approach for the isolation of this biologically important plasma protease inhibitor.
    Prograis LJ; Hammer CH; Katusha K; Frank MM
    J Immunol Methods; 1987 May; 99(1):113-22. PubMed ID: 3553333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current diagnostic possibilities in hereditary angioedema and acquired angioedema].
    Dick W; Cullmann W
    Immun Infekt; 1985 May; 13(3):113-8. PubMed ID: 3924818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of interaction of C1 inhibitor with complement C1s.
    Lennick M; Brew SA; Ingham KC
    Biochemistry; 1986 Jul; 25(13):3890-8. PubMed ID: 3091067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and regulation of C1 inhibitor in human skin fibroblasts.
    Katz Y; Strunk RC
    J Immunol; 1989 Mar; 142(6):2041-5. PubMed ID: 2537870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.